Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.5B | 13.1B | 14.8B | 13.6B |
| Cost of revenue | 8.1B | 10.3B | 11.9B | 11.0B |
| Gross profit | 2.4B | 2.8B | 2.9B | 2.6B |
| Operating expense | ||||
| Research & development | 466.7M | 412.5M | 637.9M | 607.7M |
| Selling general and admin | 248.7M | 369.3M | 271.5M | 316.9M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.7B | 2.0B | 2.0B | 1.7B |
| Non operating interest income | ||||
| Income | 330.4M | 297.0M | 309.6M | 317.8M |
| Expense | 1.9M | 1.9M | 2.2M | 2.4M |
| Other income expense | — | — | — | — |
| Pretax income | 1.8B | 2.0B | 2.2B | 2.0B |
| Tax provision | 331.8M | 205.3M | 454.7M | 395.0M |
| Net income | 1.5B | 1.8B | 1.8B | 1.6B |
| Basic EPS | 18.1 | — | 22.5 | 20.1 |
| Diluted EPS | 17.7 | — | 22.0 | 19.4 |
| Basic average shares | 80.7M | — | 79.8M | 79.1M |
| Diluted average shares | 82.7M | — | 81.5M | 81.9M |
| EBITDA | 2.9B | 3.2B | 3.1B | 2.5B |
| Net income from continuing op. | 1.8B | 2.0B | 2.2B | 2.0B |
| Minority interests | 2.2M | -4.4M | 1.8M | -2.3M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |